The major concern for any NMRA is to protect information that is considered 'commercial in confidence', and therefore not to be revealed, on account of the potential damage to the commercial entity that has provided such information to the regulator for the purpose of obtaining registration of a medicine or medical device.
The purpose of this provision is therefore to protect parties who submit sensitive and potentially valuable information to the NMRA when seeking regulatory approval from suffering prejudice through unauthorised disclosure.
Fittingly, he also added a win at Bowling Green, getting a Bracket 3 victory during an NMRA
The company is also unveiling its 2010 Saleen S281 at the NMRA
A new board of directors made up of both NMRA
and SPAAR members will be installed shortly after the merger takes effect.
In measuring the market, Master Foods gives NMRA
figures from the year end, based on a 1.
will also produce a final document -- The North American Medical Research Agenda.
Conduct a review and assessment of the market potential and business opportunities as well as the future potential of NMRA
products and services of various business models and prepare a report contaming in-depth analysis on the various business option*
The regulatory framework for nurses and midwives administered by NMRAs
in each jurisdiction have been established specifically to protect the community from substandard care provided by registered and enrolled nurses and midwives.
The consultative process will continue to be utilized to inform the detailed project design, which will enhance the capacities of the NMRAs
of ECOWAS member countries for efficient and effective medicines registration processes via a collaborative regional approach that builds on the successes in Eastern Africa.
Finally, the third step is to seek approval with the NMRAs
of the target countries.
The project will continue to support capacity building of NMRAs
, including support for additional staff training in areas of project management, assessment of quality and safety of medicines, and GMP inspections and twinning of newly established NMRAs
with existing NMRAs
in the region and implementation of quality management systems, including internal and external quality audits.